Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Triglycerides and risk of atherosclerotic cardiovascular disease: An update

(2021) Michel Farnier et al.   Archives of Cardiovascular Diseases

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia

(2021) Laurens F. Reeskamp et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease

(2021) Pyry Helkkula et al.   PLoS Genetics

Triglycerides and Residual Atherosclerotic Risk

(2021) Sergio Raposeiras-Roubin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals”

(2020) Alan T. Remaley et al.   ATHEROSCLEROSIS

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

(2020) Jan Borén et al.   EUROPEAN HEART JOURNAL

Regulation of intestinal lipid metabolism: current concepts and relevance to disease

(2020) Chih-Wei Ko et al.   Nature Reviews Gastroenterology & Hepatology

A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia

(2020) Maureen Sampson et al.   JAMA Cardiology

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

(2020) Alan Chait et al.   DIABETES

Triglycerides and remnant cholesterol associated with risk of aortic valve stenosis: Mendelian randomization in the Copenhagen General Population Study

(2020) Morten Kaltoft et al.   EUROPEAN HEART JOURNAL

LDL subclass lipidomics in atherogenic dyslipidemia: effect of statin therapy on bioactive lipids and dense LDL

(2020) M. John Chapman et al.   JOURNAL OF LIPID RESEARCH

Causes and Consequences of Hypertriglyceridemia

(2020) Chris J. Packard et al.   Frontiers in Endocrinology

Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia

(2020) Claudia Stefanutti   Current Atherosclerosis Reports

Remnant lipoproteins

(2020) Carlos A. Aguilar Salinas et al.   CURRENT OPINION IN LIPIDOLOGY

Regulation of lipoprotein lipase-mediated lipolysis of triglycerides

(2020) Debapriya Basu et al.   CURRENT OPINION IN LIPIDOLOGY

Cholesterol crystals and atherosclerosis

(2020) Yvonne Baumer et al.   EUROPEAN HEART JOURNAL

Angiopoietin-like protein 3 (ANGPTL3) governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance

(2020) Rene C. Adam et al.   JOURNAL OF LIPID RESEARCH

Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?

(2020) Michel R. Langlois et al.   Current Cardiology Reports

Genetics of Hypertriglyceridemia

(2020) Jacqueline S. Dron et al.   Frontiers in Endocrinology

LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase

(2020) Liya Wu et al.   CIRCULATION RESEARCH

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia

(2020) Daniel Gaudet et al.   EUROPEAN HEART JOURNAL

Evinacumab for Homozygous Familial Hypercholesterolemia

(2020) Frederick J. Raal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hypertriglyceridemia—Causes, Significance, and Approaches to Therapy

(2020) Leinys S. Santos-Baez et al.   Frontiers in Endocrinology

Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes

(2020) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Triglyceride-Rich Lipoprotein Remnants and Cardiovascular Disease

(2020) Edward K Duran et al.   CLINICAL CHEMISTRY

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

(2020) Stephen J. Nicholls et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins

(2020) Mie Balling et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Lipase and Its Regulators: An Unfolding Story

(2020) Shuangcheng Alivia Wu et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Investigation of human apoB48 metabolism using a new, integrated non-steady-state model of apoB48 and apoB100 kinetics

(2019) E. Björnson et al.   JOURNAL OF INTERNAL MEDICINE

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population

(2019) Anette Varbo et al.   ANNALS OF NEUROLOGY

Postprandial Hypertriglyceridaemia Revisited In The Era Of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement

(2019) Genovefa D. Kolovou et al.   Current Vascular Pharmacology

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

(2019) Martin Adiels et al.   DIABETES OBESITY & METABOLISM

Efficacy and safety of evolocumab in individuals with type 2 diabetes mellitus: primary results of the randomised controlled BANTING study

(2019) Robert S. Rosenson et al.   DIABETOLOGIA

ApoC-III ASO Promotes Tissue LPL Activity in Absence of ApoE-Mediated TRL Clearance

(2019) Bastian Ramms et al.   JOURNAL OF LIPID RESEARCH

A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals

(2019) Mie Balling et al.   ATHEROSCLEROSIS

Glucose and GLP-2 (Glucagon-Like Peptide-2) Mobilize Intestinal Triglyceride by Distinct Mechanisms

(2019) Priska Stahel et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia

(2019) Zahid Ahmad et al.   CIRCULATION

Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association

(2019) Ann C. Skulas-Ray et al.   CIRCULATION

Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes: A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials

(2019) Nicholas A. Marston et al.   CIRCULATION

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome

(2019) Joseph L. Witztum et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

(2019) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Altered HDL metabolism in metabolic disorders: insights into the therapeutic potential of HDL

(2019) Nicholas Hui et al.   CLINICAL SCIENCE

Lomitapide and Mipomersen—Inhibiting Microsomal Triglyceride Transfer Protein (MTP) and apoB100 Synthesis

(2019) Dirk J. Blom et al.   Current Atherosclerosis Reports

Clinical review on triglycerides

(2019) Ulrich Laufs et al.   EUROPEAN HEART JOURNAL

Impact of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab on the postprandial responses of triglyceride-rich lipoproteins in type II diabetic subjects

(2019) Marja-Riitta Taskinen et al.   Journal of Clinical Lipidology

Apolipoprotein B48 metabolism in chylomicrons and very low‐density lipoproteins and its role in triglyceride transport in normo‐ and hypertriglyceridemic human subjects

(2019) E. Björnson et al.   JOURNAL OF INTERNAL MEDICINE

Cholesterol Crystals are Associated with Carotid Plaque Vulnerability: An Optical Coherence Tomography Study

(2019) Xuan Shi et al.   Journal of Stroke & Cerebrovascular Diseases

Apolipoprotein C3 induces inflammation and organ damage by alternative inflammasome activation

(2019) Stephen Zewinger et al.   NATURE IMMUNOLOGY

Extracellular Lipids Accumulate in Human Carotid Arteries as Distinct Three-Dimensional Structures and Have Proinflammatory Properties

(2018) Satu Lehti et al.   AMERICAN JOURNAL OF PATHOLOGY

Macrophages Shed Excess Cholesterol in Unique Extracellular Structures Containing Cholesterol MicrodomainsHighlights

(2018) Xueting Jin et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial

(2018) Antonio J. Vallejo-Vaz et al.   CIRCULATION

Atherogenic postprandial remnant lipoproteins; VLDL remnants as a causal factor in atherosclerosis

(2018) Katsuyuki Nakajima et al.   CLINICA CHIMICA ACTA

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

(2018) Michel R. Langlois et al.   CLINICAL CHEMISTRY

Regulation of intestinal lipid and lipoprotein metabolism by the proglucagon-derived peptides glucagon like peptide 1 and glucagon like peptide 2

(2018) Erin E. Mulvihill   CURRENT OPINION IN LIPIDOLOGY

Alternative macrophages in atherosclerosis: not always protective!

(2018) Benoit Pourcet et al.   JOURNAL OF CLINICAL INVESTIGATION

Recent Advances in Triacylglycerol Mobilization by the Gut

(2018) Changting Xiao et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

(2018) Aruna D. Pradhan et al.   AMERICAN HEART JOURNAL

Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism

(2018) Gissette Reyes-Soffer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Low-Grade Inflammation in the Association Between Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis: A Study of More Than 115000 Individuals from the General Population

(2018) Signe E. J. Hansen et al.   CLINICAL CHEMISTRY

The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk

(2018) Pratik B Sandesara et al.   ENDOCRINE REVIEWS

Mipomersen and its use in familial hypercholesterolemia

(2018) Johnathon Seth Parham et al.   EXPERT OPINION ON PHARMACOTHERAPY

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

(2018) Scott M. Grundy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

(2017) Brian A. Ference et al.   EUROPEAN HEART JOURNAL

Association of Rare and Common Variation in the Lipoprotein Lipase Gene With Coronary Artery Disease

(2017) Amit V. Khera et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weekday variation in triglyceride concentrations in 1.8 million blood samples

(2017) Jörn Jaskolowski et al.   JOURNAL OF LIPID RESEARCH

ANGPTL3 Deficiency and Protection Against Coronary Artery Disease

(2017) Nathan O. Stitziel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

(2017) Jan Oscarsson et al.   Lipids in Health and Disease

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

(2017) A. Michael Lincoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease

(2017) Frederick E. Dewey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

(2017)   NEW ENGLAND JOURNAL OF MEDICINE

Pathophysiological relevance of macrophage subsets in atherogenesis

(2017) Luca Liberale et al.   THROMBOSIS AND HAEMOSTASIS

Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy HumansClinical Perspective

(2016) Gissette Reyes-Soffer et al.   CIRCULATION

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Increased Remnant Cholesterol Explains Part of Residual Risk of All-Cause Mortality in 5414 Patients with Ischemic Heart Disease

(2016) A.-M. K. Jepsen et al.   CLINICAL CHEMISTRY

Central nervous system regulation of intestinal lipid and lipoprotein metabolism

(2016) Sarah Farr et al.   CURRENT OPINION IN LIPIDOLOGY

The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis

(2016) Jan Borén et al.   CURRENT OPINION IN LIPIDOLOGY

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol

(2016) Reijo Laaksonen et al.   EUROPEAN HEART JOURNAL

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

(2016) Alberico L. Catapano et al.   EUROPEAN HEART JOURNAL

VLDL Triglyceride Kinetics in Lean, Overweight, and Obese Men and Women

(2016) Bettina Mittendorfer et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

(2016) Philip L.S.M. Gordts et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism

(2016) Ilenia Minicocci et al.   JOURNAL OF LIPID RESEARCH

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease

(2016) Frederick E. Dewey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Remnant Lipoprotein Cholesterol and Incident Coronary Heart Disease: The Jackson Heart and Framingham Offspring Cohort Studies

(2016) Parag H. Joshi et al.   Journal of the American Heart Association

Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis

(2016) Simon B. Pedersen et al.   JAMA Internal Medicine

Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?

(2016) Geesje M. Dallinga-Thie et al.   Current Cardiology Reports

New Insights into the Regulation of Chylomicron Production

(2015) Satya Dash et al.   Annual Review of Nutrition

Extreme Nonfasting Remnant Cholesterol vs Extreme LDL Cholesterol as Contributors to Cardiovascular Disease and All-Cause Mortality in 90000 Individuals from the General Population

(2015) A. Varbo et al.   CLINICAL CHEMISTRY

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

(2015) John S. Millar et al.   JOURNAL OF CLINICAL INVESTIGATION

Cholesterol Crystals Associate With Coronary Plaque Vulnerability In Vivo

(2015) Yu Kataoka et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Fasting Triglycerides Predict Recurrent Ischemic Events in Patients With Acute Coronary Syndrome Treated With Statins

(2015) Gregory G. Schwartz et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dysfunctional HDL and atherosclerotic cardiovascular disease

(2015) Robert S. Rosenson et al.   Nature Reviews Cardiology

Transcriptional regulation of hepatic lipogenesis

(2015) Yuhui Wang et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia

(2015) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Postprandial hypertriglyceridemia as a coronary risk factor

(2014) Jan Borén et al.   CLINICA CHIMICA ACTA

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

(2014) M. Cuchel et al.   EUROPEAN HEART JOURNAL

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

(2014) Ron Do et al.   NATURE

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeting APOC3 in the Familial Chylomicronemia Syndrome

(2014) Daniel Gaudet et al.   NEW ENGLAND JOURNAL OF MEDICINE

Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice

(2013) Erin M. Foley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: Impact on small HDL particles

(2013) Marcus Ståhlman et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Elevated Remnant Cholesterol Causes Both Low-Grade Inflammation and Ischemic Heart Disease, Whereas Elevated Low-Density Lipoprotein Cholesterol Causes Ischemic Heart Disease Without Inflammation

(2013) Anette Varbo et al.   CIRCULATION

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Postprandial metabolism of meal triglyceride in humans

(2012) Jennifer E. Lambert et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

The characteristics of remnant lipoproteins in the fasting and postprandial plasma

(2012) Katsuyuki Nakajima et al.   CLINICA CHIMICA ACTA

Hepatic ABC transporters and triglyceride metabolism

(2012) John S. Parks et al.   CURRENT OPINION IN LIPIDOLOGY

The interaction of familial and secondary causes of hypertriglyceridemia: Role in pancreatitis

(2012) John D. Brunzell et al.   Journal of Clinical Lipidology

Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects

(2011) Marja-Riitta Taskinen et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein CIII

(2011) Henry N. Ginsberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Lipolysis of triglyceride-rich lipoproteins, vascular inflammation, and atherosclerosis

(2011) Eric A. Schwartz et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Fish oil — How does it reduce plasma triglycerides?

(2011) Gregory C. Shearer et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)

(2011) et al.   EUROPEAN HEART JOURNAL

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib

(2011) Ronald M. Krauss et al.   JOURNAL OF LIPID RESEARCH

Lipoprotein(a) as a cardiovascular risk factor: current status

(2010) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

(2010) Peter Duewell et al.   NATURE

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Cholesterol Crystals Activate the NLRP3 Inflammasome in Human Macrophages: A Novel Link between Cholesterol Metabolism and Inflammation

(2010) Kristiina Rajamäki et al.   PLoS One

Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins

(2009) Pia Davidsson et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Oro-sensory perception of dietary lipids: New insights into the fat taste transduction

(2009) Naim Akhtar Khan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Inflammation associated with the postprandial lipolysis of triglyceriderich lipoproteins by lipoprotein lipase

(2009) Laura J. Higgins et al.   Current Atherosclerosis Reports

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

(2009) M. J. Chapman et al.   EUROPEAN HEART JOURNAL

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

(2009) The Emerging Risk Factors Collaboration*   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Brief oral stimulation, but especially oral fat exposure, elevates serum triglycerides in humans

(2008) Richard D. Mattes   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

(2008) Martin Adiels et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Fasting and Nonfasting Lipid Levels

(2008) Anne Langsted et al.   CIRCULATION

Why is HDL functionally deficient in type 2 diabetes?

(2008) Anatol Kontush et al.   Current Diabetes Reports

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

(2008) R. Scott et al.   DIABETES CARE

Nonfasting Triglycerides and Risk of Ischemic Stroke in the General Population

(2008) Jacob J. Freiberg   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry

(2008) Philipp Wiesner et al.   JOURNAL OF LIPID RESEARCH

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

(2008) Limin Wang et al.   JOURNAL OF LIPID RESEARCH

Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial

(2008) Michael Miller et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE